Great question, Joe. Those are always very material to our ability to drive that organic growth, as you will know. I’m actually pretty encouraged by the most – in particular, our most recent lines, the NHLBI contractors, one in which – it’s bringing new opportunities for new workforce, but we’re in a position of really leveraging a real strong track record that we’ve had with that particular customer, particularly within the competitive environment. While it is a multiple award contract, we have over the last 4, 5 years, exhibited a real, real strong ability to have a higher win rate in this community. So we’re hoping that with our valued enterprise capabilities that, that will continue. We have been disappointed as you all know, with the government’s slowdown up until relatively recently as it relates to issuing new work on our previous IDIQs. I think I mentioned to you before, last time that our Defense Health Agency, Omnibus 4 IDIQ still has yet to issue the first request for a proposal. And we have been on standby with a real strong team for quite some time. That still continues to be the case, but we are starting to hear some – we’ve been very proactive on that, and we’re starting to hear that they are prepared, they’re getting closer and closer to prepared to issue a few of those. Similarly, we’ve had just slower than anticipated than government announced work on our – some of our other ones within NIH. And then lastly, as you know, many of us across the industry, we’re anxiously looking for the government to resolve their process on the largest would be IDIQs, the CIO-SP4, it is where the biomedical research technology work is for largely health and human services agency is to be conducted, one that has been very strategic for DLH. We’re fortunate that in the heritage contract, the – our GRSi has some presence and some opportunities to pursue, but those will expand once CIO-SP4 before gets resolved. It has been delayed by I think, over 100 protests, largely by some of the small business partners. And that has slipped any opportunities for us to prime any of the unrestricted work that we’ve had our eyes on for a better part of the year. But the upside of that is we do think that, like I said, with the approval, getting beyond the Budget Control Act that should give some of our agency’s greater clarity and budget and the ability to issue some of the recurring work.